APA (7th ed.) Citation

C, G., A, V., M, F., I, D., A, L., R, T., . . . D, T. (2025). MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation. Molecular oncology, 19(8), 2366. https://doi.org/10.1002/1878-0261.13806

Chicago Style (17th ed.) Citation

C, Guérin, et al. "MET Variants with Activating N-lobe Mutations Identified in Hereditary Papillary Renal Cell Carcinomas Still Require Ligand Stimulation." Molecular Oncology 19, no. 8 (2025): 2366. https://doi.org/10.1002/1878-0261.13806.

MLA (9th ed.) Citation

C, Guérin, et al. "MET Variants with Activating N-lobe Mutations Identified in Hereditary Papillary Renal Cell Carcinomas Still Require Ligand Stimulation." Molecular Oncology, vol. 19, no. 8, 2025, p. 2366, https://doi.org/10.1002/1878-0261.13806.